MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial

K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: To assess the barriers and facilitators of dietary adherence among people with Parkinson’s disease (PD) following an 8-week Mediterranean-ketogenic and 8-week MCT-supplemented Mediterranean diet.

Background: Emerging research suggests beneficial effects of both Mediterranean and ketogenic diets in PD, with hybrid Mediterranean-ketogenic interventions potentially conferring maximal benefit. However, the acceptability of these interventions in individuals living with PD has yet to be established.

Method: All participants (n=48) in a phase II crossover study (NCT05469997) comparing an 8-week Mediterranean-ketogenic with an 8-week MCT-supplemented Mediterranean diet were invited to complete post-intervention semi-structured interviews. The trial was run out of a tertiary Movement Disorders clinic in Vancouver, BC, Canada. Sixty-seven semi-structured interviews were conducted with a total of 44 trial participants. Interview questions were formulated based on the Theory of Planned Behaviour (TPB). Thematic analysis of interview transcripts was performed using a combination of inductive and deductive techniques. Individual codes were aggregated into 2-6 subthemes for each TPB construct.

Results: Dietitian and care partner support were consistently identified as key facilitators of adherence, while attitudes towards the perceived health benefits and palatability of each dietary intervention varied among participants. Major adherence barriers included social pressures, conflicting cultural dietary preferences, high costs of specialty food items and time-intensive meal preparation. PD-related adherence challenges included loss of fine motor skills, gastrointestinal dysfunction, apathy, sensory disturbances, cognitive slowing and overwhelm with the combined burden of diet and medication management.

Conclusion: Dietary interventions in PD should consider multiple bidirectional relationships between eating behaviour and health-related quality of life, while harnessing available social supports to best enable behaviour change.

To cite this abstract in AMA style:

K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell. Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/barriers-and-facilitators-of-adherence-to-mediterranean-ketogenic-and-mct-supplemented-mediterranean-diets-in-parkinsons-disease-a-qualitative-secondary-analysis-from-a-random-order-crossove/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/barriers-and-facilitators-of-adherence-to-mediterranean-ketogenic-and-mct-supplemented-mediterranean-diets-in-parkinsons-disease-a-qualitative-secondary-analysis-from-a-random-order-crossove/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley